No attachments available.
Erlotinib Tablets
Contact and place of performance
Adam Hernandez
USA
No narrative description provided for this notice.
The National Institutes of Health, specifically the NIH National Cancer Institute, has issued an award notice for the procurement of Erlotinib Tablets under solicitation number 75N91020Q00004. This requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. The procurement was designated as a Small Business Administration (SBA) set-aside.
The award notice was published and last updated on January 27, 2020. Adam Hernandez is the designated point of contact for this action, which designates the United States as the place of performance. The solicitation was finalized with zero attachments included in the notice metadata.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.